These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30664303)

  • 1. Impulsiveness as a predictor of topiramate response for cocaine use disorder.
    Blevins D; Wang XQ; Sharma S; Ait-Daoud N
    Am J Addict; 2019 Feb; 28(2):71-76. PubMed ID: 30664303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impulsiveness as a moderator of amphetamine treatment response for cocaine use disorder among ADHD patients.
    Blevins D; Choi CJ; Pavlicova M; Martinez D; Mariani JJ; Grabowski J; Levin FR
    Drug Alcohol Depend; 2020 Aug; 213():108082. PubMed ID: 32485656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate for the treatment of cocaine addiction: a randomized clinical trial.
    Johnson BA; Ait-Daoud N; Wang XQ; Penberthy JK; Javors MA; Seneviratne C; Liu L
    JAMA Psychiatry; 2013 Dec; 70(12):1338-46. PubMed ID: 24132249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users.
    Levin FR; Mariani JJ; Pavlicova M; Choi CJ; Mahony AL; Brooks DJ; Bisaga A; Dakwar E; Carpenter KM; Naqvi N; Nunes EV; Kampman K
    Drug Alcohol Depend; 2020 Jan; 206():107700. PubMed ID: 31753736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, placebo-controlled trial of topiramate for pathological gambling.
    Berlin HA; Braun A; Simeon D; Koran LM; Potenza MN; McElroy SL; Fong T; Pallanti S; Hollander E
    World J Biol Psychiatry; 2013 Mar; 14(2):121-8. PubMed ID: 21486110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.
    Baldaçara L; Cogo-Moreira H; Parreira BL; Diniz TA; Milhomem JJ; Fernandes CC; Lacerda AL
    J Clin Psychiatry; 2016 Mar; 77(3):398-406. PubMed ID: 27046312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory-Focused Cognitive Therapy for Cocaine Use Disorder: Theory, Procedures and Preliminary Evidence From an External Pilot Randomised Controlled Trial.
    Marsden J; Goetz C; Meynen T; Mitcheson L; Stillwell G; Eastwood B; Strang J; Grey N
    EBioMedicine; 2018 Mar; 29():177-189. PubMed ID: 29478874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
    Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
    J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate Combined with Cognitive Restructuring for the Treatment of Gambling Disorder: A Two-Center, Randomized, Double-Blind Clinical Trial.
    de Brito AM; de Almeida Pinto MG; Bronstein G; Carneiro E; Faertes D; Fukugawa V; Duque A; Vasconcellos F; Tavares H
    J Gambl Stud; 2017 Mar; 33(1):249-263. PubMed ID: 27256372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in the treatment of cocaine use disorder.
    Prince V; Bowling KC
    Am J Health Syst Pharm; 2018 Jan; 75(1):e13-e22. PubMed ID: 29273608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence.
    Rass O; Umbricht A; Bigelow GE; Strain EC; Johnson MW; Mintzer MZ
    Psychol Addict Behav; 2015 Mar; 29(1):237-46. PubMed ID: 25365653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of impulsivity on cocaine use and retention in treatment.
    Moeller FG; Dougherty DM; Barratt ES; Schmitz JM; Swann AC; Grabowski J
    J Subst Abuse Treat; 2001 Dec; 21(4):193-8. PubMed ID: 11777668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
    Claudino AM; de Oliveira IR; Appolinario JC; Cordás TA; Duchesne M; Sichieri R; Bacaltchuk J
    J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
    Hoopes SP; Reimherr FW; Hedges DW; Rosenthal NR; Kamin M; Karim R; Capece JA; Karvois D
    J Clin Psychiatry; 2003 Nov; 64(11):1335-41. PubMed ID: 14658948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.
    Blevins D; Seneviratne C; Wang XQ; Johnson BA; Ait-Daoud N
    Drug Alcohol Depend; 2021 Nov; 228():109074. PubMed ID: 34600264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
    McElroy SL; Shapira NA; Arnold LM; Keck PE; Rosenthal NR; Wu SC; Capece JA; Fazzio L; Hudson JI
    J Clin Psychiatry; 2004 Nov; 65(11):1463-9. PubMed ID: 15554757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features.
    Nourredine M; Jurek L; Angerville B; Longuet Y; de Ternay J; Derveaux A; Rolland B
    CNS Drugs; 2021 Feb; 35(2):177-213. PubMed ID: 33591567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulsivity and decision making in older and younger cocaine-dependent participants: A preliminary study.
    Johns SE; Wang Q; Straub LK; Moeller FG
    Am J Addict; 2018 Oct; 27(7):557-559. PubMed ID: 30260087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of Topiramate-Related Working Memory Impairment Is Modulated by Plasma Concentration and Working Memory Capacity.
    Callisto SP; Illamola SM; Birnbaum AK; Barkley CM; Bathena SPR; Leppik IE; Marino SE
    J Clin Pharmacol; 2020 Sep; 60(9):1166-1176. PubMed ID: 32297992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.